Hoxton Financial’s ResMed RMD Stock Holding History

Hoxton Financial’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-76	Closed	-$4K	–	541
2013 Q4	$4K	Buy	+76	New	+$3.85K	﹤0.01%	562
2013 Q3	–	Sell	-54	Closed	-$2K	–	531
2013 Q2	$2K	Buy	+54	New	+$2.56K	﹤0.01%	580

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Hoxton Financial's RMD Position: Q1 2014 in Review

Hoxton Financial sold out of ResMed (RMD) in Q1 2014, closing a stake of 76 shares — an estimated $4K sold.

Hoxton Financial first reported a position in RMD in Q2 2013 and held it in 2 quarters. The position peaked at $4K in Q4 2013. 318 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

Hoxton Financial reported no remaining ResMed position as of Q1 2014 after selling out during the quarter.
Hoxton Financial sold 76 ResMed shares in Q1 2014, an estimated $4K.
Hoxton Financial first reported a position in ResMed in Q2 2013 and held it in 2 quarters.
Hoxton Financial's ResMed position peaked at $4K in Q4 2013.
318 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.